Sai Parenterals IPO Listing 2026 – Allotment, Demat Credit & BSE SME Debut

Sai Parenterals IPO is set to make its stock market debut on April 2, 2026, with shares scheduled to be listed on both BSE and NSE.

The IPO opened for subscription on March 24, 2026, and closed on March 27, 2026, attracting moderate investor participation during the bidding period.

The company aimed to raise approximately ₹409 crore through the IPO, which includes a mix of fresh issue and offer for sale (OFS).

Image Reference : https://www.bseindia.com/

Sai Parenteral’s IPO Listing Details 

The price band was fixed at ₹372 to ₹392 per share, with a minimum lot size of 38 shares, requiring a minimum investment of around ₹14,896 for retail investors.

The IPO allotment was finalized on March 30, 2026, while shares were credited to investors’ demat accounts on April 1, 2026, ahead of the listing.

In terms of investor allocation, 50% of the issue was reserved for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 35% for retail investors.

About Company

Sai Parenterals, founded in 2001, operates in the pharmaceutical sector, focusing on manufacturing injectable medicines and other formulations. The company also provides contract manufacturing services and supplies products across domestic and international markets.

Overall, the IPO witnessed modest subscription levels (around 1.08 times), indicating a relatively cautious response from investors ahead of its market debut.